FINAL_Ceribell_Logo.jpeg

CeriBell is a medical device company based in Silicon Valley founded by two faculty members at Stanford University. The technology is a novel approach to acquiring and interpreting electroencephalography (EEG) data: the gold standard for critical neurological conditions such as seizures or other forms of altered mental state. Ceribell recently has not only expanded their platform commercially, but also partnered with pharmaceutical companies and hospitals to use in drug trials and clinical care.